A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2023; you can also visit the original URL.
The file type is application/pdf
.
The state of the art in core-shell type lipid polymer hybrid nanocarriers and beyond
[post]
2022
unpublished
The need to enhance the therapeutic effect of drugs and thus reduce their side effects is the reason for the emergence of today's drug delivery systems. With the advent of nanotechnology, numerous molecular structures - from carbon nanotubes to polymeric materials - have been developed, and significant progress has been made. However, all these promising results do not mean that drug delivery systems are a solution to all problems in pharmaceutical technology. This is because any drug delivery
doi:10.26434/chemrxiv-2022-8gc2q-v2
fatcat:h7a2fjn7ingidbpqr3jpr6swse